SCHEMBL18026505

SCHEMBL18026505

CCC(C)(CC(C)(C)C(=O)NCCNC(=O)OC(C)(C)C)C(=O)NCCCOc1ccc2c(C)cc(=O)oc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.49
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2B6 P20813 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ CYP3A43 Q9HB55 1/20 0.49
▸ MAOA P21397 2/20 0.47
▸ MAOB P27338 2/20 0.47
▸ AR P10275 1/20 0.47
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ BCHE P06276 2/20 0.44
▸ ACHE P22303 2/20 0.44
▸ KDM4E B2RXH2 6/20 0.44
▸ ALDH1A1 P00352 5/20 0.44
▸ HPGD P15428 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ GLA P06280 2/20 0.44
▸ GAA P10253 2/20 0.44
▸ HIF1A Q16665 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18026503 0.89 MAOA (0.49) MAOAMAOBARACHEKDM4E
SCHEMBL12617766 0.88 CYP1A1 (0.60) CYP1A1CYP2D6CYP2B6CYP2C19CYP3A43
SCHEMBL26195635 0.78 AR (0.58) MAOAMAOBARCA12CA1
SCHEMBL18026501 0.76 MAOB (0.37) MAOAMAOBARBCHEACHE
SCHEMBL16471370 0.74 CA9 (0.56) CYP1A1CYP2D6CYP2B6CYP2C19CYP3A43
SCHEMBL21724418 0.74 CA12 (0.56) CYP1A1CYP2D6CYP2B6CYP2C19CYP3A43
SCHEMBL4446592 0.73 AGER (0.60) CYP1A1CYP2D6CYP2B6CYP2C19CYP3A43
SCHEMBL2803970 0.73 KMT2A (0.59) ARCA12CA1CA9KDM4E
SCHEMBL7915768 0.72 ALDH1A1 (0.58) MAOAMAOBARKDM4EALDH1A1
SCHEMBL9612697 0.71 KDM4E (0.72) CYP1A1CYP2D6CYP2B6CYP2C19CYP3A43

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160243047-A1 SURFACE FUNCTIONALIZED, HOST-GUEST POLYMER NANO-ASSEMBLIES AND METHODS THEREOF UNIV MASSACHUSETTS (US) 2016-08-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160243047-A1 SURFACE FUNCTIONALIZED, HOST-GUEST POLYMER NANO-ASSEMBLIES AND METHODS THEREOF MSN, CD44, EPHA2 CYP1A1 2585/4885CYP2D6 1358/4885CYP2B6 1944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback